• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微囊化对Wistar大鼠胃肠道活力及某些血液生化因子水平的影响。

Effect of microencapsulation on viability in the gastrointestinal tract and level of some blood biochemical factors in wistar rats.

作者信息

Ghorbani-Choboghlo Hassan, Nikaein Donya, Khosravi Ali-Reza, Rahmani Reza, Farahnejad Zohreh

机构信息

Department of Medical Mycology, AJA University of Medical Sciences, Tehran, Iran.

Mycology Research Center, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

出版信息

Iran J Microbiol. 2019 Apr;11(2):160-165.

PMID:31341571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6635316/
Abstract

BACKGROUND AND OBJECTIVES

Probiotics are live microorganisms that, when administered in an adequate amount, confer a health benefit on the host through the gut. is a widespread yeast found in nature. This microorganism has been used as a probiotic agent in recent years. In this study, the effect of microencapsulation on survival rate of in the simulated gastrointestinal tract medium and the impact of microencapsulated on some serum biochemical factors in a rat model was evaluated.

MATERIALS AND METHODS

30 male wistar rats were divided into three groups (control, rats receiving microencapsulated , and rats receiving alone). The probiotic was gavaged at a dosage of 2 gr/kg BW for 8 weeks. Blood was collected from rats at the end of the treatment period and biochemical factors were measured using Mancompany kits.

RESULTS

The results showed a significant increase in viability of microencapsulated in comparison with free (p<0.05). Weight of rats in probiotic treated groups was significantly higher in comparison with the control group (p<0.05). Moreover, probiotic treatment reduced mean levels of triglycerides, cholesterol, free blood sugar and liver enzymes in rats.

CONCLUSION

Microencapsulation could increase the survival rate of yeast probiotics in the gastrointestinal tract; however, more studies are needed for better understanding of the exact effect of microencapsulation on probiotics' function.

摘要

背景与目的

益生菌是一类活的微生物,当给予足够数量时,可通过肠道为宿主带来健康益处。酿酒酵母是一种在自然界广泛存在的酵母。近年来,这种微生物已被用作益生菌制剂。在本研究中,评估了微囊化对酿酒酵母在模拟胃肠道介质中的存活率的影响以及微囊化酿酒酵母对大鼠模型中某些血清生化因子的影响。

材料与方法

将30只雄性Wistar大鼠分为三组(对照组、接受微囊化酿酒酵母的大鼠组和仅接受酿酒酵母的大鼠组)。以2克/千克体重的剂量对大鼠进行灌胃益生菌,持续8周。在治疗期结束时从大鼠采集血液,并使用曼康公司的试剂盒测量生化因子。

结果

结果显示,与游离酿酒酵母相比,微囊化酿酒酵母的存活率显著提高(p<0.05)。益生菌治疗组大鼠的体重与对照组相比显著更高(p<0.05)。此外,益生菌治疗降低了大鼠甘油三酯、胆固醇、空腹血糖和肝酶的平均水平。

结论

微囊化可提高酵母益生菌在胃肠道中的存活率;然而,需要更多研究以更好地了解微囊化对益生菌功能的确切影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba71/6635316/eea712536387/IJM-11-160-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba71/6635316/eea712536387/IJM-11-160-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba71/6635316/eea712536387/IJM-11-160-g001.jpg

相似文献

1
Effect of microencapsulation on viability in the gastrointestinal tract and level of some blood biochemical factors in wistar rats.微囊化对Wistar大鼠胃肠道活力及某些血液生化因子水平的影响。
Iran J Microbiol. 2019 Apr;11(2):160-165.
2
Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.酿酒酵母和酿酒酵母 var. boulardii 的转录组差异:基于启动子序列变异性的宿主存活和益生菌活性线索。
Genomics. 2021 Mar;113(2):530-539. doi: 10.1016/j.ygeno.2020.11.034. Epub 2021 Jan 20.
3
Health-promoting properties of as a probiotic; characteristics, isolation, and applications in dairy products.作为益生菌的健康促进特性;特性、分离及其在乳制品中的应用。
Crit Rev Food Sci Nutr. 2023;63(4):457-485. doi: 10.1080/10408398.2021.1949577. Epub 2021 Jul 13.
4
Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.老年患者应用布拉氏酵母菌散(Saccharomyces cerevisiae var. boulardii)益生菌治疗后发生真菌血症。
Rev Argent Microbiol. 2020 Jan-Mar;52(1):27-30. doi: 10.1016/j.ram.2019.04.002. Epub 2019 Jun 28.
5
Alcoholic and non-alcoholic rosé wines made with Saccharomyces cerevisiae var. boulardii probiotic yeast.含酿酒酵母 var. boulardii 益生菌酵母的含酒精和不含酒精的桃红葡萄酒。
Arch Microbiol. 2023 Apr 20;205(5):201. doi: 10.1007/s00203-023-03534-8.
6
Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.益生菌酵母布拉氏酵母菌的抗氧化特性及整体代谢物筛选
J Sci Food Agric. 2017 Jul;97(9):3039-3049. doi: 10.1002/jsfa.8147. Epub 2017 Jan 19.
7
Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast var. .高醋酸生产益生菌酵母 var. 的独特抗生素效力的遗传基础。
Genome Res. 2019 Sep;29(9):1478-1494. doi: 10.1101/gr.243147.118.
8
Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.利用酿酒酵母变种巴氏酵母与酿酒酵母共发酵,生产具有潜在健康附加值的精酿啤酒。
Int J Food Microbiol. 2018 Nov 2;284:22-30. doi: 10.1016/j.ijfoodmicro.2018.06.028. Epub 2018 Jul 2.
9
Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.利用益生菌酵母酿酒酵母 var. boulardii 构建微生物细胞工厂生产新琼寡糖。
Microb Cell Fact. 2021 Aug 18;20(1):160. doi: 10.1186/s12934-021-01644-w.
10
: What Makes It Tick as Successful Probiotic?是什么使其成为成功的益生菌?
J Fungi (Basel). 2020 Jun 4;6(2):78. doi: 10.3390/jof6020078.

引用本文的文献

1
Effect of Nanoencapsulated Alginate-Synbiotic on Gut Microflora Balance, Immunity, and Growth Performance of Growing Rabbits.纳米包封藻酸盐-合生元对生长兔肠道微生物群平衡、免疫力和生长性能的影响
Polymers (Basel). 2021 Nov 30;13(23):4191. doi: 10.3390/polym13234191.

本文引用的文献

1
Saccharomyces cerevisiae fungemia after probiotic treatment in an intensive care unit patient.重症监护病房患者在接受益生菌治疗后发生酵母菌血症。
J Mycol Med. 2018 Mar;28(1):218-221. doi: 10.1016/j.mycmed.2017.09.003. Epub 2017 Nov 11.
2
Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial.布拉氏酵母菌预防抗生素相关性腹泻:一项随机、双盲、安慰剂对照试验。
Open Forum Infect Dis. 2016 Jan 29;3(1):ofw011. doi: 10.1093/ofid/ofw011. eCollection 2016 Jan.
3
Microencapsulation of Saccharomyces cerevisiae and its evaluation to protect in simulated gastric conditions.
酿酒酵母的微囊化及其在模拟胃部条件下的保护效果评估。
Iran J Microbiol. 2015 Dec;7(6):338-42.
4
Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.益生菌对血糖控制的影响:一项随机对照试验的系统评价和荟萃分析
PLoS One. 2015 Jul 10;10(7):e0132121. doi: 10.1371/journal.pone.0132121. eCollection 2015.
5
Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea.布拉氏酵母菌 CNCM I-745 可缩短急性腹泻患儿腹泻持续时间、减少急诊治疗时间和住院时间。
Benef Microbes. 2015;6(4):415-21. doi: 10.3920/BM2014.0086. Epub 2015 Feb 12.
6
Probiotics for prevention of necrotizing enterocolitis in preterm infants.益生菌用于预防早产儿坏死性小肠结肠炎
Evid Based Child Health. 2014 Sep;9(3):584-671. doi: 10.1002/ebch.1976.
7
Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.专家共识文件。国际益生菌和益生元科学协会关于益生菌术语的范围和适当使用的共识声明。
Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14. doi: 10.1038/nrgastro.2014.66. Epub 2014 Jun 10.
8
Effect of whey protein agglomeration on spray dried microcapsules containing Saccharomyces boulardii.乳清蛋白聚集对含布拉氏酵母菌喷雾干燥微胶囊的影响。
Food Chem. 2013 Dec 1;141(3):1782-8. doi: 10.1016/j.foodchem.2013.04.093. Epub 2013 May 9.
9
Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice.布拉氏酵母菌抑制组织炎症和细菌易位,作为其抵抗鼠伤寒沙门氏菌感染的保护机制之一。
Microbes Infect. 2013 Apr;15(4):270-9. doi: 10.1016/j.micinf.2012.12.007. Epub 2013 Jan 30.
10
A meta-analysis of probiotic efficacy for gastrointestinal diseases.益生菌治疗胃肠道疾病的疗效的荟萃分析。
PLoS One. 2012;7(4):e34938. doi: 10.1371/journal.pone.0034938. Epub 2012 Apr 18.